RxDoctor Payments DataLook up a doctor →

Henry Rodriguez

Pediatric Endocrinology · Tampa, FLNPI 1962434662

Payments from drug & device makers

$1,696,848in general payments, 2019–2025

Across 1,195 payments — averaging $1419.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$903K
  • Sanofi-aventis U.S. LLC$181K
  • Boehringer Ingelheim$167K
  • Eli Lilly$148K
  • Novo Nordisk AS$100K
  • Mannkind Corporation$75K
  • plus $123K from 16 others
$34,431in research payments, 2019–2025

Across 21 payments — averaging $1639.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$23K
  • Novo Nordisk AS$9K
  • Eli Lilly$2K
  • Mannkind Corporation$106

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,696,848 in reported general payments places this provider in the 95th percentile of 102 pediatric endocrinology providers in Florida.

See all pediatric endocrinology providers in Florida

Other pediatric endocrinology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →